UnitedHealthcare has increased its operating earnings outlook to at least $12 billion for 2026, with adjusted EPS guidance rising to $19.50–$20. This improvement is driven by Medicare Advantage cost trends running below the original 10% assumption, leading to expected Medicare margins above 3%. The company generated $11.1 billion in quarterly operating cash flow, supporting significant share buybacks and dividend increases. However, commercial medical cost trends above 11% remain a risk, potentially delaying margin recovery beyond 2027.
Luigi Mangione pleaded guilty in a New York federal court to stalking that led to the killing of UnitedHealthcare CEO Brian Thompson in December 2024. His plea came just weeks before a state trial for Thompson's murder was set to begin. Mangione face...
The Schwab U.S. Dividend Equity ETF (SCHD) focuses on high-quality companies with strong financials and a history of growing dividends, rather than chasing the highest yields. While its yield is around 3% to 4%, SCHD has delivered strong long-term re...
In 2026, the Schwab U.S. Dividend Equity ETF (SCHD) leads with a 25.6% year-to-date return, driven by its focus on current yield, value sectors, and energy exposure. Meanwhile, the Vanguard Dividend Appreciation ETF (VIG) prioritizes dividend growth ...
Luigi Mangione is expected to plead guilty in his federal stalking case related to the 2024 killing of UnitedHealthcare CEO Brian Thompson in Manhattan. The plea is scheduled during a pretrial conference in U.S. District Court, while Mangione also fa...
Over the past decade, iShares Core Dividend Growth ETF (DGRO) returned 257.35%, outperforming Schwab US Dividend Equity ETF (SCHD) which returned 235.33%. The difference stems from SCHD's stricter stock selection criteria requiring 10 years of consec...
